PCMI
IONS icon

Princeton Capital Management Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Princeton Capital Management Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-37,200
Closed -$1M – 71
2013
Q2 		$1M Buy
+37,200
New +$791K 0.96% 40

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Princeton Capital Management Inc's IONS Position: Q3 2013 in Review

Princeton Capital Management Inc sold out of Ionis Pharmaceuticals (IONS) in Q3 2013, closing a stake of 37,200 shares — an estimated $1M sold.

Princeton Capital Management Inc first reported a position in IONS in Q2 2013 and held it in 1 quarter. The position peaked at $1M in Q2 2013. 204 funds tracked by Wall St. Rank hold IONS as of Q3 2013.

  • Princeton Capital Management Inc reported no remaining Ionis Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Princeton Capital Management Inc sold 37,200 Ionis Pharmaceuticals shares in Q3 2013, an estimated $1M.
  • Princeton Capital Management Inc first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Princeton Capital Management Inc's Ionis Pharmaceuticals position peaked at $1M in Q2 2013.
  • 204 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2013.

Based on Princeton Capital Management Inc's 13F filing for Q3 2013, filed 8 Nov 2013.